Clinical Trial Update: Pembrolizumab in Combination With R-ICE Chemotherapy in Relapsed/Refractory Diffuse Large B-cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating pembrolizumab plus R-ICE chemotherapy as salvage therapy for relapsed/refractory diffuse large B-cell lymphoma; the study stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Etoposide (Etoposide)
• IFOSFAMIDE (IFOSFAMIDE)
• KEYTRUDA (PEMBROLIZUMAB)
• Rituximab (rituximab)

Snippet

Sponsor: University of Southampton | Conditions: Diffuse Large B Cell Lymphoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING